Department of Health and Human Services February 19, 2008 – Federal Register Recent Federal Regulation Documents

National Center for Complementary and Alternative Medicine; Notice of Closed Meeting
Document Number: 08-715
Type: Notice
Date: 2008-02-19
Agency: Department of Health and Human Services, National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed Meetings
Document Number: 08-714
Type: Notice
Date: 2008-02-19
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 08-713
Type: Notice
Date: 2008-02-19
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Child Health and Human Development; Notice of Closed Meeting
Document Number: 08-712
Type: Notice
Date: 2008-02-19
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Dental & Craniofacial Research; Notice of Closed Meetings
Document Number: 08-711
Type: Notice
Date: 2008-02-19
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting
Document Number: 08-710
Type: Notice
Date: 2008-02-19
Agency: Department of Health and Human Services, National Institutes of Health
National Library of Medicine; Notice of Meeting
Document Number: 08-709
Type: Notice
Date: 2008-02-19
Agency: Department of Health and Human Services, National Institutes of Health
National Library of Medicine, Notice of Meeting
Document Number: 08-708
Type: Notice
Date: 2008-02-19
Agency: Department of Health and Human Services, National Institutes of Health
Submission for OMB review; comment request
Document Number: 08-697
Type: Notice
Date: 2008-02-19
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
Submission for OMB Review; Comment Request
Document Number: 08-696
Type: Notice
Date: 2008-02-19
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
Memorandum of Understanding Between the Division of Select Agents and Toxins Center for Disease Control and Prevention and the Food and Drug Administration
Document Number: 08-686
Type: Notice
Date: 2008-02-19
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between FDA and the Division of Select Agents and Toxins (DSAT) of the Centers for Disease Control and Prevention (CDC). The purpose of this MOU is to establish a procedure to allow CDC/DSAT to confirm that FDA has accepted or approved, under the authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq), an Investigational New Drug application (IND), a request to establish an Investigational New Animal Drug file (INAD), or an Investigational Device Exemption application (IDE) for a clinical trial involving the use of an investigational product that is, bears, or contains a select agent or toxin.
Memorandum of Understanding Between the Walter Reed Army Institute for Research, the Food and Drug Administration, and the F. Edward Herbert School of Medicine of the Uniformed Services University of the Health Sciences
Document Number: 08-685
Type: Notice
Date: 2008-02-19
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Walter Reed Army Institute of Research, FDA, and the F. Edward Herbert School of Medicine of the Uniformed Services University of the Health Sciences. This MOU identifies the terms of collaboration between the three Federal entities in the coordination of the established Clinical Pharmacology Fellowship Training Program. Specifically, this collaboration provides for active duty Army, Air Force, Navy, and Public Health Service Medical Corps officers in the fellowship program to arrange a 2 to 4 month internship within FDA's Center for Drug Evaluation and Research (CDER) through CDER's Office of Clinical Pharmacology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.